Current and historical daily PE Ratio for JCR Pharmaceuticals Co Ltd (
TSE:4552
) from 2011 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. JCR Pharmaceuticals stock (TSE:4552) PE ratio as of Jun 06 2024 is 12.91.
More Details
JCR Pharmaceuticals Co Ltd (TSE:4552) PE Ratio (TTM) Chart
JCR Pharmaceuticals Co Ltd (TSE:4552) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1241
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| JCR Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-06 | 12.9 | 2024-04-01 | 19.1 |
| 2024-06-05 | 12.9 | 2024-03-29 | 19.5 |
| 2024-06-04 | 13.3 | 2024-03-28 | 19.5 |
| 2024-06-03 | 13.1 | 2024-03-27 | 20.4 |
| 2024-05-31 | 13.1 | 2024-03-26 | 20.3 |
| 2024-05-30 | 12.3 | 2024-03-25 | 20.4 |
| 2024-05-29 | 12.2 | 2024-03-22 | 20.9 |
| 2024-05-28 | 12.5 | 2024-03-21 | 20.8 |
| 2024-05-27 | 12.8 | 2024-03-19 | 20.7 |
| 2024-05-24 | 12.8 | 2024-03-18 | 20.4 |
| 2024-05-23 | 13.1 | 2024-03-15 | 20.7 |
| 2024-05-22 | 13.3 | 2024-03-14 | 20.6 |
| 2024-05-21 | 14.1 | 2024-03-13 | 20.8 |
| 2024-05-20 | 14.5 | 2024-03-12 | 20.6 |
| 2024-05-17 | 14.2 | 2024-03-11 | 20.2 |
| 2024-05-16 | 14.0 | 2024-03-08 | 20.5 |
| 2024-05-15 | 14.3 | 2024-03-07 | 20.8 |
| 2024-05-14 | 14.6 | 2024-03-06 | 20.9 |
| 2024-05-13 | 14.8 | 2024-03-05 | 20.8 |
| 2024-05-10 | 18.2 | 2024-03-04 | 21.3 |
| 2024-05-09 | 18.2 | 2024-03-01 | 20.9 |
| 2024-05-08 | 18.2 | 2024-02-29 | 21.1 |
| 2024-05-07 | 18.4 | 2024-02-28 | 21.8 |
| 2024-05-02 | 18.4 | 2024-02-27 | 21.7 |
| 2024-05-01 | 18.5 | 2024-02-26 | 21.0 |
| 2024-04-30 | 18.6 | 2024-02-22 | 21.2 |
| 2024-04-26 | 18.1 | 2024-02-21 | 21.3 |
| 2024-04-25 | 18.1 | 2024-02-20 | 21.7 |
| 2024-04-24 | 18.5 | 2024-02-19 | 21.7 |
| 2024-04-23 | 18.4 | 2024-02-16 | 21.8 |
| 2024-04-22 | 18.5 | 2024-02-15 | 21.1 |
| 2024-04-19 | 17.8 | 2024-02-14 | 21.8 |
| 2024-04-18 | 18.2 | 2024-02-13 | 23.1 |
| 2024-04-17 | 18.2 | 2024-02-09 | 23.4 |
| 2024-04-16 | 18.8 | 2024-02-08 | 23.6 |
| 2024-04-15 | 18.8 | 2024-02-07 | 23.4 |
| 2024-04-12 | 19.0 | 2024-02-06 | 23.6 |
| 2024-04-11 | 18.0 | 2024-02-05 | 24.6 |
| 2024-04-10 | 18.4 | 2024-02-02 | 24.6 |
| 2024-04-09 | 18.4 | 2024-02-01 | 24.8 |
| 2024-04-08 | 18.5 | 2024-01-31 | 25.6 |
| 2024-04-05 | 18.5 | 2024-01-30 | 24.6 |
| 2024-04-04 | 18.4 | 2024-01-29 | 24.1 |
| 2024-04-03 | 18.5 | 2024-01-26 | 25.8 |
| 2024-04-02 | 18.3 | 2024-01-25 | 26.2 |
JCR Pharmaceuticals Co Ltd (TSE:4552) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
JCR Pharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : JP3701000006
Share Class Description:
TSE:4552: Ordinary SharesDescription
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers